SAT0255 Clinical and Radiographic Outcomes at 2 Years and the Effect of TOCILIZUMAB Discontinuation following Sustained Remission in the Second and Third Year of the ACT-RAY Study

T.W. Huizinga; P.G. Conaghan; E. Martin-Mola; G. Schett; H. Amital; R.M. Xavier; O. Troum; M. Aassi; C. Bernasconi; M. Dougados

doi:10.1136/annrheumdis-2014-eular.1434

Citation Tools

EULAR 2014: Scientific Abstracts

Poster Presentations. Rheumatoid arthritis - other biologic treatment

SAT0255 Clinical and Radiographic Outcomes at 2 Years and the Effect of TOCILIZUMAB Discontinuation following Sustained Remission in the Second and Third Year of the ACT-RAY Study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Cite this article as:: Huizinga T, Conaghan P, Martin-Mola E, et al

SAT0255 Clinical and Radiographic Outcomes at 2 Years and the Effect of TOCILIZUMAB Discontinuation following Sustained Remission in the Second and Third Year of the ACT-RAY Study

Annals of the Rheumatic Diseases 2014;73:685.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password